Nanosonics Limited ( (AU:NAN) ) has issued an update.
Nanosonics Limited has announced a change in the director’s interest, with Gerard Dalbosco acquiring 20,000 ordinary shares in the company. This acquisition, valued at approximately $87,139.75, reflects a significant investment by the director, potentially indicating confidence in the company’s future performance and strategic direction.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, specializing in infection prevention solutions. The company is known for its innovative products, particularly in the area of ultrasound probe disinfection, and focuses on enhancing patient safety and reducing healthcare-associated infections.
YTD Price Performance: 44.39%
Average Trading Volume: 981
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $820.5M
Learn more about NAN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com